Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Vitamin C Injections Slow Tumor Growth In Mice
http://www.medicalnewstoday.com/articles/117252.php
High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the <i>Proceedings of the National Academy of Sciences.
Cold Spring Harbor Protocols Highlights Gene Silencing, Cancer Cell Biology Methods
http://www.medicalnewstoday.com/articles/117227.php
Combining the specificity of small interfering RNA (siRNA) silencing with the versatility of lentiviral vectors gives researchers a powerful tool for the investigation of gene function both in vivo and in vitro.
8,000 People Join The Team Sarcoma Initiative To Fight A Rare Cancer
http://www.medicalnewstoday.com/articles/117181.php
From its humble beginnings in 2003, when seven people who called themselves "Team Sarcoma" biked 200 miles in Louisiana, the Team Sarcoma Initiative has become an international movement. <b>Sarcoma Knows No Borders</b>More than 8,000 people worldwide participated in this year's Initiative, surpassing the 3,400 who participated last year.
Electro-Optical Sciences Completes Patient Accrual In MelaFind(R) Pivotal Trial For Early Melanoma Detection
http://www.medicalnewstoday.com/articles/117172.php
Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) announced that patient accrual in the MelaFind® pivotal trial was completed last week. MelaFind is a non-invasive, point-of-care instrument designed and developed by EOS to assist in the early diagnosis of melanoma, the deadliest form of skin cancer.
Depression Found To Hasten Decline In Cancer Patients
http://www.medicalnewstoday.com/articles/117166.php
Depression causes patients with advanced cancer to die sooner than they should, say scientists at the University of Liverpool. In a six-month study patients who were found to be depressed had a 7% increased chance of dying and this percentage increased depending on the severity of the depression.
Video Games Can Enhance Effectiveness Of Medical Treatment For Young Cancer Patients
http://www.medicalnewstoday.com/articles/117163.php
Video games are among the most popular entertainment media in the world. Now, groundbreaking research shows that a specially designed video game can promote positive behaviors in young cancer patients that enhance the effectiveness of medical treatment.
MDL Receives GBP600k In New Funding Round For World-Beating Cancer Diagnosis And Treatment Device
http://www.medicalnewstoday.com/articles/117160.php
Successful results and growing sales of Michelson Diagnostics Ltd's (MDL) Optical Coherence Technology (OCT) systems have encouraged investors to place a further GBP600K into the business to help develop the in vivo technology.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
FDA Reviewing Biomoda Submission For Cancer Screening Study
http://www.medicalnewstoday.com/articles/117186.php
Biomoda, Inc. (OTC Bulletin Board: BMOD) (<a href="http://www.biomoda.com" target="_blank" rel="nofollow">http://www.biomoda.com</a>), a development stage medical diagnostics company, submitted to the FDA a pre-IDE (Investigational Device Exemption) protocol for a clinical study using Biomoda's proprietary assay for detection of early lung cancer in veterans.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms Are More Common In Shanghai Than Thought
http://www.medicalnewstoday.com/articles/117180.php
<a href="http://www.springerlink.com/content/r1623x466m24237r/" target="_blank" rel="nofollow">A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China</a> published online in the International Journal of Hematology shows significant differences in frequency of subtypes of lymphoma and other lymphoid neoplasms between China and the West.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Pharmion Ltd Withdraws Its Marketing Authorisation Application For Orplatna (satraplatin), Europe
http://www.medicalnewstoday.com/articles/117291.php
The European Medicines Agency (EMEA) has been formally notified by Celgene Europe Ltd of Pharmion Ltd's decision to withdraw the application for a centralised marketing authorisation for the medicine Orplatna (satraplatin) 10 mg and 50 mg capsules.
US Preventive Services Task Force Updates Prostate Cancer Screening Recommendations - No Benefits For Over 75s
http://www.medicalnewstoday.com/articles/117221.php
The U.S. Preventive Services Task Force (USPSTF), updating its 2002 report, now recommends against routine prostate cancer screening for men over the age of 75. More evidence is needed to determine if men under 75 could benefit from screening.
Men Age 75 And Older Should Not Be Screened For Prostate Cancer
http://www.medicalnewstoday.com/articles/117197.php
Men age 75 and older should not be screened for prostate cancer, and younger men should discuss the benefits and harms of the prostate-specific antigen (PSA) test with their clinicians before being tested, according to a new recommendation from the U.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment